Home › Calculator › BLRX Dividend Calculator 2026
BLRX Dividend Calculator 2026
No dividendHealthcareBioLineRx Ltd. · NASDAQ
Price: $1.98 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
BLRX is not a dividend-focused stock
BLRX pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
BLRX Dividend Yield
BioLineRx Ltd. (BLRX) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BLRX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About BioLineRx Ltd. (BLRX) — Dividend Analysis 2026
BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational product, Motixafortide, a peptide, has successfully concluded pivotal Phase 3 clinical trials for mobilizing stem cells in autologous transplants, and Phase 2a trials targeting pancreatic cancer. This compound is currently progressing through Phase 2 studies for metastatic pancreatic adenocarcinoma and Phase 1b trials for acute respiratory distress syndrome linked to COVID-19 and other viral infections. Additionally, Motixafortide is being investigated for its therapeutic potential in solid tumors and acute myeloid leukemia. The company's pipeline also includes AGI-134, an immuno-oncology agent presently undergoing Phase 1/2a clinical evaluations for various solid tumors. Furthermore, BioLineRx is advancing BL-5010, a custom-designed, proprietary pen-like device intended for the non-surgical removal of skin lesions. BioLineRx maintains strategic alliances, notably a collaboration with MSD in the domain of cancer immunotherapy, and an agreement with MD Anderson Cancer Center to explore Motixafortide combined with KEYTRUDA (pembrolizumab) for pancreatic cancer. They also have a licensing deal with Perrigo Company plc for the over-the-counter sale of BL-5010.
BLRX Dividend & DRIP — Frequently Asked Questions
Does BLRX pay a dividend?
No. BioLineRx Ltd. (BLRX) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of BLRX?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does BLRX have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. BLRX has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to BLRX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BLRX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BLRX position with:
🌍 BLRX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BLRX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BLRX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BLRX Dividend Payment Schedule
BLRX pays quarterly — 4 times per year. Ex-div: —.
📊 BLRX vs Healthcare Benchmarks
How BLRX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BLRX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BLRX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2016-10-05 | 49,800 | $0.84 | $41.7K | ||
| Other | 2017-10-05 | 19,800 | $0.92 | $18.2K | ||
| Other | 2018-10-05 | 19,800 | $0.89 | $17.7K | ||
| Other | 2019-10-02 | 199,800 | $0.36 | $71.1K | ||
| Other | 2020-10-02 | 79,800 | $0.37 | $29.4K | ||
| Other | 2021-10-02 | 79,800 | $0.39 | $31.0K | ||
| Other | 2024-10-03 | 360,000 | $0.09 | $30.6K | ||
| Other | 2023-10-03 | 360,000 | $0.08 | $29.2K | ||
| Other | 2025-01-01 | 2,055,000 | $0.05 | $106.9K | ||
| Other | 2016-10-05 | 49,800 | $0.84 | $41.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare BLRX with peers: BLRX vs ADAP · BLRX vs ADTX · BLRX vs AIMD
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BLRX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
BioLineRx Ltd. (BLRX) is currently trading at $1.98, trading near its 52-week low. It does not currently pay a regular dividend.
Does BLRX Pay a Dividend? BioLineRx Ltd. Dividend Status
BioLineRx Ltd. (BLRX) is a healthcare stock trading at $1.98. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest BLRX News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your BLRX DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.